Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome

Supplemental Digital Content is available in the text.

[1]  P. Seferovic,et al.  [2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)]. , 2019, Giornale italiano di cardiologia.

[2]  A. Zaman,et al.  Outcomes Following Percutaneous Coronary Intervention in Non–ST-Segment–Elevation Myocardial Infarction Patients With Coronary Artery Bypass Grafts , 2018, Circulation. Cardiovascular interventions.

[3]  A. Bayés‐Genís,et al.  Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction. , 2016, European journal of internal medicine.

[4]  A. Briggs,et al.  Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS) , 2016, Open Heart.

[5]  B. Bendz,et al.  Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial , 2016, The Lancet.

[6]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[7]  W. van Gaal,et al.  Predictors and outcomes of early coronary angiography in patients with prior coronary artery bypass surgery presenting with non-ST elevation myocardial infarction , 2014, Open Heart.

[8]  J. Spratt,et al.  Percutaneous intervention for chronic total occlusion: integrating strategies to address an unmet need , 2013, Heart.

[9]  P. Bannon,et al.  A meta-analysis of randomized controlled trials on mid-term angiographic outcomes for radial artery versus saphenous vein in coronary artery bypass graft surgery. , 2013, Annals of cardiothoracic surgery.

[10]  G. Stone,et al.  Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2012, JACC. Cardiovascular interventions.

[11]  S. de Servi,et al.  Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. , 2012, JACC. Cardiovascular interventions.

[12]  G. Schuler,et al.  Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). , 2012, European heart journal.

[13]  Rajvir Singh,et al.  Acute Coronary Syndrome in Patients with Prior Coronary Artery Bypass Surgery: Observations from a 20-Year Registry in a Middle-Eastern Country , 2012, PloS one.

[14]  Jeroen J. Bax,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .

[15]  T. Lauer,et al.  Kardiologische Aspekte der präoperativen Risikostratifizierung , 2011 .

[16]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[17]  J. Messenger,et al.  Association of prior coronary artery bypass graft surgery with quality of care of patients with non-ST-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines. , 2010, American heart journal.

[18]  S. Pocock,et al.  Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.

[19]  S. Yusuf,et al.  Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines , 2013 .

[20]  A. Zaman,et al.  Non-invasive assessment of saphenous vein graft patency in asymptomatic patients. , 2009, The British journal of radiology.

[21]  M. Sabatine,et al.  Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. , 2008, JAMA.

[22]  Colin Berry,et al.  Importance of collateral circulation in coronary heart disease. , 2007, European heart journal.

[23]  J. Tijssen,et al.  Early invasive versus selectively invasive management for acute coronary syndromes. , 2005, The New England journal of medicine.

[24]  W. Hueb,et al.  [Comparative study of the results of coronary artery bypass grafting and angioplasty for myocardial revascularization in patients with equivalent multivessel disease]. , 2005, Arquivos brasileiros de cardiologia.

[25]  A. Kastrati,et al.  Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[26]  E. Hannan,et al.  Predictors of readmission for complications of coronary artery bypass graft surgery. , 2003, JAMA.

[27]  Ameet Bakhai,et al.  Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial , 2002, The Lancet.

[28]  K. Fox,et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.

[29]  P. Widimsky,et al.  Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. , 2002, European heart journal.

[30]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[31]  L. Michalis,et al.  Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study). , 2000, European heart journal.

[32]  M. Galli.  [Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[33]  L. Wallentin,et al.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.

[34]  R. Califf,et al.  Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. , 2000, Circulation.

[35]  R. Kleiger,et al.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. , 1999, The New England journal of medicine.

[36]  F. Ragmin.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[37]  S. Pocock,et al.  Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting , 1998, The Lancet.

[38]  W. O’Neill,et al.  A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. , 1998, Journal of the American College of Cardiology.

[39]  R. Kleiger,et al.  Correction: Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. , 1998, The New England journal of medicine.

[40]  S. Pocock,et al.  Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.

[41]  CABRI Trial Participants,et al.  First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation) , 1995, The Lancet.

[42]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[43]  Volkmar Falk,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca , 2014, European heart journal.

[44]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .

[45]  Douglas Weaver,et al.  Third universal definition of myocardial infarction. , 2012, Circulation.

[46]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[47]  J. Gore,et al.  Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization. , 2010, American heart journal.

[48]  B. Buxton,et al.  Patencies of 2127 arterial to coronary conduits over 15 years. , 2004, The Annals of thoracic surgery.

[49]  B. Buxton,et al.  Patencies of 2,127 arterial to coronary conduits over 15 years , 2004 .

[50]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[51]  S. Nitter‐Hauge,et al.  Risk factors of recurrent angina pectoris and of non-fatal myocardial infarction after coronary artery bypass surgery. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.